CLINICAL_TRIALS
trial_result
· 2013-01-17
Clinical Trial Update: Schistosoma Haematobium Infections and Praziquantel [Phase 3]
Summary
Phase 3 clinical trial update for praziquantel in treating Schistosomiasis caused by Schistosoma haematobium; the study is reported as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Khartoum | Conditions: Schistosomiasis | Phase 3 | Status: COMPLETED